Annual Meeting 2015: Novel JAK Inhibitor Pacritinib Proves Effective for Easing Symptoms of Myelofibrosis - 101271

Spotlight
Video

Annual Meeting 2015: Novel JAK Inhibitor Pacritinib Proves Effective for Easing Symptoms of Myelofibrosis

EMJ has 458 videos Subscribe Here

Loading........
Description: Findings from the PERSIST-1 study of patients with myelofibrosis suggest that pacritinib is significantly more effective than best available therapy (BAT), which includes a range of off-label treatments. At 24 weeks of treatment, 19.1% of patients on the pacritinib arm experienced spleen shrinkage, compared to only 4.7% of patients on the BAT arm.

Presented by Ruben A. Mesa, MD, Mayo Clinic Cancer Center, Scottsdale, AZ, at ASCO 2015

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 06/03/15
Added : 3 years ago



Recommended

Nothing found.

More From EMJ

Nothing found.